| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active Surveillance for Early Stage Lung Cancer
|
Payne, Ryan G.
|
|
|
23 |
3 |
p. 226-235
|
artikel
|
| 2 |
An Extensive-stage Small-cell Lung Cancer Case With Preexisting Lambert-Eaton Myasthenic Syndrome Successfully Treated With an Immune Checkpoint Inhibitor
|
Sakaguchi, Tadashi
|
|
|
23 |
3 |
p. e273-e275
|
artikel
|
| 3 |
Association of Operability With Post-Treatment Mortality in Early-Stage Non-Small Cell Lung Cancer
|
Stokes, William A.
|
|
|
23 |
3 |
p. e231-e237
|
artikel
|
| 4 |
Bronchial Artery Chemoembolization for Hemoptysis in Advanced Primary Lung Cancer
|
Xiaobing, Li
|
|
|
23 |
3 |
p. e203-e209
|
artikel
|
| 5 |
CheckMate 73L: A Phase 3 Study Comparing Nivolumab Plus Concurrent Chemoradiotherapy Followed by Nivolumab With or Without Ipilimumab Versus Concurrent Chemoradiotherapy Followed by Durvalumab for Previously Untreated, Locally Advanced Stage III Non-Small-Cell Lung Cancer
|
De Ruysscher, Dirk
|
|
|
23 |
3 |
p. e264-e268
|
artikel
|
| 6 |
Chemotherapy Plus Immunotherapy Versus Chemotherapy Plus Bevacizumab Versus Chemotherapy Alone in EGFR-Mutant NSCLC After Progression on Osimertinib
|
White, Maya N.
|
|
|
23 |
3 |
p. e210-e221
|
artikel
|
| 7 |
Clinical Effectiveness and Safety of Anti-PD-(L)1 Therapy Among Older Adults With Advanced Non-Small Cell Lung Cancer
|
Altan, Mehmet
|
|
|
23 |
3 |
p. 236-243
|
artikel
|
| 8 |
Comments on ‘The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors’
|
Takada, Kazuki
|
|
|
23 |
3 |
p. e174-e175
|
artikel
|
| 9 |
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial
|
Heymach, John V.
|
|
|
23 |
3 |
p. e247-e251
|
artikel
|
| 10 |
Detection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT
|
Sodji, Quaovi H.
|
|
|
23 |
3 |
p. 282-289
|
artikel
|
| 11 |
Detection of second primary lung cancers on surveillance imaging following stereotactic ablative radiotherapy for non-small cell lung cancer
|
Aldin, Muhtada Kamal
|
|
|
23 |
3 |
p. e222-e230
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
23 |
3 |
p. A13
|
artikel
|
| 13 |
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer
|
Hellyer, Jessica A.
|
|
|
23 |
3 |
p. 264-272
|
artikel
|
| 14 |
Implementing Real-World RECIST-based Tumor Response Assessment in Patients With Metastatic Non-small Cell Lung Cancer
|
Izano, Monika A.
|
|
|
23 |
3 |
p. 191-194
|
artikel
|
| 15 |
Intra-tumor and Inter-tumor Heterogeneity in MET Exon 14 Skipping Mutations and Co-mutations in Pulmonary Pleomorphic Carcinomas
|
Fujino, Toshio
|
|
|
23 |
3 |
p. e185-e195
|
artikel
|
| 16 |
Large Cell Neuroendocrine Carcinoma Transformation as a Mechanism of Acquired Resistance to Osimertinib in Non-small Cell Lung Cancer: Case Report and Literature Review
|
Lee, Matthew
|
|
|
23 |
3 |
p. e276-e282
|
artikel
|
| 17 |
Lung Cancer Stage Shift as a Result of COVID-19 Lockdowns in New York City, a Brief Report
|
Mynard, Nathan
|
|
|
23 |
3 |
p. e238-e242
|
artikel
|
| 18 |
Meta-analysis of Lobectomy and Sublobar Resection for Stage I Non-small Cell Lung Cancer With Spread Through Air Spaces
|
Li, Jialong
|
|
|
23 |
3 |
p. 208-213
|
artikel
|
| 19 |
Overall Survival and Safety With Pemetrexed/Platinum ± Anti-VEGF Followed by Pemetrexed ± Anti-VEGF Maintenance in Advanced Nonsquamous Non–Small-Cell Lung Cancer: A Pooled Analysis of 4 Randomized Studies
|
Garon, Edward B.
|
|
|
23 |
3 |
p. 253-263
|
artikel
|
| 20 |
PD-1 iNhibitor and chemotherapy with concurrent IRradiation at VAried tumor sites in advanced Non-small cell lung cAncer: the Prospective Randomized Phase 3 NIRVANA-Lung Trial
|
Doyen, Jérôme
|
|
|
23 |
3 |
p. e252-e256
|
artikel
|
| 21 |
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
|
Remon, Jordi
|
|
|
23 |
3 |
p. e243-e246
|
artikel
|
| 22 |
Phase III Clinical Trial for the Combination of Erlotinib Plus Ramucirumab Compared With Osimertinib in Previously Untreated Advanced or Recurrent Non–Small Cell Lung Cancer Positive for the L858R Mutation of EGFR: REVOL858R (WJOG14420L)
|
Haratake, Naoki
|
|
|
23 |
3 |
p. e257-e263
|
artikel
|
| 23 |
Prognostic Impact of Mediastinal Lymph Node Dissection in Octogenarians With Lung Cancer: JACS1303
|
Nakao, Masayuki
|
|
|
23 |
3 |
p. e176-e184
|
artikel
|
| 24 |
Reply to Letter to the Editor
|
Oh, Michael S.
|
|
|
23 |
3 |
p. e173
|
artikel
|
| 25 |
Role of Postoperative Radiotherapy in Patients With Completely Resected pIIIA-N2 Non-Small Cell Lung Cancer
|
Yamasaki, Nanami
|
|
|
23 |
3 |
p. e171-e172
|
artikel
|
| 26 |
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non–Small Cell Lung Cancer: Results From a Phase 1b Trial
|
Wong, Deborah J.
|
|
|
23 |
3 |
p. 273-281
|
artikel
|
| 27 |
Safety of MET Tyrosine Kinase Inhibitors in Patients With MET Exon 14 Skipping Non-small Cell Lung Cancer: A Clinical Review
|
Cortot, Alexis
|
|
|
23 |
3 |
p. 195-207
|
artikel
|
| 28 |
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction
|
Belluomini, Lorenzo
|
|
|
23 |
3 |
p. e269-e272
|
artikel
|
| 29 |
Table of Contents
|
|
|
|
23 |
3 |
p. A15-A19
|
artikel
|
| 30 |
The Application of Pigtail Catheters in Postoperative Drainage of Lung Cancer
|
Li, Xianshuai
|
|
|
23 |
3 |
p. e196-e202
|
artikel
|
| 31 |
The Role of Thoracic Surgery in Small Cell Lung Cancer – A Large Longitudinal Analysis (2002-2015) Based on Real-World Data
|
Kauffmann-Guerrero, Diego
|
|
|
23 |
3 |
p. 244-252
|
artikel
|
| 32 |
Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non–Squamous Non–Small Cell Lung Cancer
|
Govindan, Ramaswamy
|
|
|
23 |
3 |
p. 214-225
|
artikel
|
Tijdschrift beschrijving